# Cadre Holdings, Inc.: financial statements, quarterly

CDRE · NYSE · CIK 1860543 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cdre.md) · [Financials](/companies/cdre/financials.md) · [Filings](/companies/cdre/filings.md) · [Insiders](/companies/cdre/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cdre/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [125](/filings/0001558370-24-014638.md) | [125 d](/filings/0001104659-26-025862.md) | [138](/filings/0001558370-25-006502.md) | [144](/filings/0001558370-25-010299.md) | [109](/filings/0001104659-25-106299.md) | [176 d](/filings/0001104659-26-025862.md) | [130](/filings/0001104659-26-058670.md) | [157](/filings/0001104659-26-091151.md) | [156](/filings/0001104659-25-106299.md) | [167 d](/filings/0001104659-26-025862.md) | [155](/filings/0001104659-26-058670.md) | [207](/filings/0001104659-26-091151.md) |
| Cost of revenue | $m | [71.5](/filings/0001558370-24-014638.md) | [74.8 d](/filings/0001104659-26-025862.md) | [80.2](/filings/0001558370-25-006502.md) | [85.7](/filings/0001558370-25-010299.md) | [69.4](/filings/0001104659-25-106299.md) | [98.8 d](/filings/0001104659-26-025862.md) | [74.0](/filings/0001104659-26-058670.md) | [92.9](/filings/0001104659-26-091151.md) | [89.2](/filings/0001104659-25-106299.md) | [94.6 d](/filings/0001104659-26-025862.md) | [95.3](/filings/0001104659-26-058670.md) | [120](/filings/0001104659-26-091151.md) |
| Gross profit | $m | [53.6](/filings/0001558370-24-014638.md) | [49.8 d](/filings/0001104659-26-025862.md) | [57.6](/filings/0001558370-25-006502.md) | [58.7](/filings/0001558370-25-010299.md) | [40.0](/filings/0001104659-25-106299.md) | [77.2 d](/filings/0001104659-26-025862.md) | [56.1](/filings/0001104659-26-058670.md) | [64.2](/filings/0001104659-26-091151.md) | [66.6](/filings/0001104659-25-106299.md) | [72.6 d](/filings/0001104659-26-025862.md) | [60.2](/filings/0001104659-26-058670.md) | [87.1](/filings/0001104659-26-091151.md) |
| Selling, general and administrative | $m | [36.3](/filings/0001558370-24-014638.md) | [34.9 d](/filings/0001104659-26-025862.md) | [40.7](/filings/0001558370-25-006502.md) | [38.6](/filings/0001558370-25-010299.md) | [34.0](/filings/0001104659-25-106299.md) | [45.0 d](/filings/0001104659-26-025862.md) | [41.8](/filings/0001104659-26-058670.md) | [45.1](/filings/0001104659-26-091151.md) | [45.6](/filings/0001104659-25-106299.md) | [50.6 d](/filings/0001104659-26-025862.md) | [48.8](/filings/0001104659-26-058670.md) | [63.2](/filings/0001104659-26-091151.md) |
| Operating income | $m | [16.7](/filings/0001558370-24-014638.md) | [12.7 d](/filings/0001104659-26-025862.md) | [12.0](/filings/0001558370-25-006502.md) | [20.0](/filings/0001558370-25-010299.md) | [5.4](/filings/0001104659-25-106299.md) | [29.4 d](/filings/0001104659-26-025862.md) | [13.6](/filings/0001104659-26-058670.md) | [14.7](/filings/0001104659-26-091151.md) | [18.7](/filings/0001104659-25-106299.md) | [20.4 d](/filings/0001104659-26-025862.md) | [7.5](/filings/0001104659-26-058670.md) | [22.5](/filings/0001104659-26-091151.md) |
| Interest expense | $m | [1.1](/filings/0001558370-23-018286.md) | [0.8 d](/filings/0001558370-24-002995.md) | [1.6](/filings/0001558370-24-007349.md) | [2.0](/filings/0001558370-25-010299.md) | [2.0](/filings/0001558370-24-014638.md) | [2.2 d](/filings/0001558370-25-002711.md) | [2.2](/filings/0001558370-25-006502.md) | [3.6](/filings/0001558370-25-010299.md) | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.3](/filings/0001558370-24-014638.md) | [2.8 d](/filings/0001104659-26-025862.md) | [2.0](/filings/0001558370-25-006502.md) | [5.0](/filings/0001558370-25-010299.md) | [1.3](/filings/0001104659-25-106299.md) | [9.7 d](/filings/0001104659-26-025862.md) | [3.4](/filings/0001104659-26-058670.md) | [5.0](/filings/0001104659-26-091151.md) | [3.9](/filings/0001104659-25-106299.md) | [5.9 d](/filings/0001104659-26-025862.md) | [0.9](/filings/0001104659-26-058670.md) | [5.5](/filings/0001104659-26-091151.md) |
| Net income | $m | [11.1](/filings/0001558370-24-014638.md) | [9.6 d](/filings/0001104659-26-025862.md) | [6.9](/filings/0001104659-25-106299.md) | [12.6](/filings/0001104659-25-106299.md) | [3.7](/filings/0001104659-25-106299.md) | [13.0 d](/filings/0001104659-26-025862.md) | [9.2](/filings/0001104659-26-091151.md) | [12.2](/filings/0001104659-26-091151.md) | [10.9](/filings/0001104659-25-106299.md) | [11.7 d](/filings/0001104659-26-025862.md) | [2.0](/filings/0001104659-26-091151.md) | [11.4](/filings/0001104659-26-091151.md) |
| Diluted EPS | $ per share | [0.29](/filings/0001558370-24-014638.md) | not reported | [0.18](/filings/0001558370-25-006502.md) | [0.31](/filings/0001558370-25-010299.md) | [0.09](/filings/0001104659-25-106299.md) | not reported | [0.23](/filings/0001104659-26-058670.md) | [0.30](/filings/0001104659-26-091151.md) | [0.27](/filings/0001104659-25-106299.md) | not reported | [0.05](/filings/0001104659-26-058670.md) | [0.26](/filings/0001104659-26-091151.md) |
| Basic EPS | $ per share | [0.29](/filings/0001558370-24-014638.md) | not reported | [0.18](/filings/0001558370-25-006502.md) | [0.31](/filings/0001558370-25-010299.md) | [0.09](/filings/0001104659-25-106299.md) | not reported | [0.23](/filings/0001104659-26-058670.md) | [0.30](/filings/0001104659-26-091151.md) | [0.27](/filings/0001104659-25-106299.md) | not reported | [0.05](/filings/0001104659-26-058670.md) | [0.27](/filings/0001104659-26-091151.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [125](/filings/0001104659-26-025862.md) | not reported | not reported | not reported | [123](/filings/0001104659-26-091151.md) | [41.3](/filings/0001104659-26-058670.md) | [54.0](/filings/0001104659-26-091151.md) |
| Current assets | $m | [237](/filings/0001558370-23-018286.md) | [246](/filings/0001558370-25-002711.md) | [269](/filings/0001558370-24-007349.md) | [295](/filings/0001558370-24-011750.md) | [286](/filings/0001558370-24-014638.md) | [328](/filings/0001104659-26-025862.md) | [333](/filings/0001558370-25-006502.md) | [381](/filings/0001558370-25-010299.md) | [386](/filings/0001104659-25-106299.md) | [366](/filings/0001104659-26-091151.md) | [319](/filings/0001104659-26-058670.md) | [348](/filings/0001104659-26-091151.md) |
| Total assets | $m | [421](/filings/0001558370-23-018286.md) | [431](/filings/0001558370-25-002711.md) | [599](/filings/0001558370-24-007349.md) | [621](/filings/0001558370-24-011750.md) | [617](/filings/0001558370-24-014638.md) | [653](/filings/0001104659-26-025862.md) | [656](/filings/0001558370-25-006502.md) | [794](/filings/0001558370-25-010299.md) | [792](/filings/0001104659-25-106299.md) | [770](/filings/0001104659-26-091151.md) | [880](/filings/0001104659-26-058670.md) | [917](/filings/0001104659-26-091151.md) |
| Current liabilities | $m | [89.7](/filings/0001558370-23-018286.md) | [95.2](/filings/0001558370-25-002711.md) | [95.6](/filings/0001558370-24-007349.md) | [93.1](/filings/0001558370-24-011750.md) | [95.1](/filings/0001558370-24-014638.md) | [94.1](/filings/0001104659-26-025862.md) | [93.7](/filings/0001558370-25-006502.md) | [106](/filings/0001558370-25-010299.md) | [106](/filings/0001104659-25-106299.md) | [104](/filings/0001104659-26-091151.md) | [141](/filings/0001104659-26-058670.md) | [162](/filings/0001104659-26-091151.md) |
| Total liabilities | $m | [231](/filings/0001558370-23-018286.md) | [234](/filings/0001558370-25-002711.md) | [329](/filings/0001558370-24-007349.md) | [321](/filings/0001558370-24-011750.md) | [316](/filings/0001558370-24-014638.md) | [341](/filings/0001104659-26-025862.md) | [339](/filings/0001558370-25-006502.md) | [462](/filings/0001558370-25-010299.md) | [452](/filings/0001104659-25-106299.md) | [452](/filings/0001104659-26-091151.md) | [544](/filings/0001104659-26-058670.md) | [570](/filings/0001104659-26-091151.md) |
| Long-term debt | $m | [130](/filings/0001558370-23-018286.md) | [128](/filings/0001558370-25-002711.md) | [201](/filings/0001558370-24-007349.md) | [198](/filings/0001558370-24-011750.md) | [195](/filings/0001558370-24-014638.md) | [212](/filings/0001104659-26-025862.md) | [209](/filings/0001558370-25-006502.md) | [299](/filings/0001558370-25-010299.md) | [295](/filings/0001104659-25-106299.md) | [291](/filings/0001104659-26-091151.md) | [350](/filings/0001104659-26-058670.md) | [354](/filings/0001104659-26-091151.md) |
| Current portion of debt | $m | [13.3](/filings/0001558370-23-018286.md) | [12.3](/filings/0001558370-25-002711.md) | [15.2](/filings/0001558370-24-007349.md) | [13.1](/filings/0001558370-24-011750.md) | [13.1](/filings/0001558370-24-014638.md) | [11.4](/filings/0001104659-26-025862.md) | [11.4](/filings/0001558370-25-006502.md) | [16.3](/filings/0001558370-25-010299.md) | [16.3](/filings/0001104659-25-106299.md) | [16.3](/filings/0001104659-26-091151.md) | [16.3](/filings/0001104659-26-058670.md) | [20.0](/filings/0001104659-26-091151.md) |
| Short-term borrowings | $m | [13.3](/filings/0001558370-23-018286.md) | [2.2](/filings/0001558370-25-002711.md) | [1.1](/filings/0001558370-24-007349.md) | not reported | not reported | [0.0](/filings/0001558370-25-002711.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [190](/filings/0001558370-24-014638.md) | [197](/filings/0001104659-26-025862.md) | [271](/filings/0001104659-25-106299.md) | [299](/filings/0001104659-25-106299.md) | [300](/filings/0001104659-25-106299.md) | [312](/filings/0001104659-26-091151.md) | [318](/filings/0001104659-26-091151.md) | [332](/filings/0001104659-26-091151.md) | [340](/filings/0001104659-25-106299.md) | [318](/filings/0001104659-26-091151.md) | [336](/filings/0001104659-26-091151.md) | [347](/filings/0001104659-26-091151.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.0 d](/filings/0001558370-24-014638.md) | [26.9 d](/filings/0001104659-26-025862.md) | [2.1](/filings/0001558370-25-006502.md) | [11.1 d](/filings/0001558370-25-010299.md) | [(5.2) d](/filings/0001104659-25-106299.md) | [23.7 d](/filings/0001104659-26-025862.md) | [17.4](/filings/0001104659-26-058670.md) | [2.6 d](/filings/0001104659-26-091151.md) | [22.5 d](/filings/0001104659-25-106299.md) | [21.3 d](/filings/0001104659-26-025862.md) | [22.5](/filings/0001104659-26-058670.md) | [22.1 d](/filings/0001104659-26-091151.md) |
| Capital expenditure | $m | [1.8 d](/filings/0001558370-24-014638.md) | [2.5 d](/filings/0001104659-26-025862.md) | [1.3](/filings/0001558370-25-006502.md) | [2.0 d](/filings/0001558370-25-010299.md) | [1.0 d](/filings/0001104659-25-106299.md) | [1.3 d](/filings/0001104659-26-025862.md) | [1.3](/filings/0001104659-26-058670.md) | [1.4 d](/filings/0001104659-26-091151.md) | [0.8 d](/filings/0001104659-25-106299.md) | [3.3 d](/filings/0001104659-26-025862.md) | [2.7](/filings/0001104659-26-058670.md) | [3.5 d](/filings/0001104659-26-091151.md) |
| Dividends paid | $m | [3.0 d](/filings/0001558370-24-014638.md) | [3.0 d](/filings/0001104659-26-025862.md) | [3.3](/filings/0001558370-25-006502.md) | [3.6 d](/filings/0001558370-25-010299.md) | [3.6 d](/filings/0001104659-25-106299.md) | [3.6 d](/filings/0001104659-26-025862.md) | [3.9](/filings/0001104659-26-058670.md) | [3.9 d](/filings/0001104659-26-091151.md) | [3.9 d](/filings/0001104659-25-106299.md) | [3.9 d](/filings/0001104659-26-025862.md) | [4.3](/filings/0001104659-26-058670.md) | [4.3 d](/filings/0001104659-26-091151.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.7](/filings/0001558370-23-018286.md) | [37.6](/filings/0001558370-24-007349.md) | [37.9](/filings/0001558370-24-011750.md) | [37.9](/filings/0001558370-24-014638.md) | [38.6](/filings/0001558370-25-006502.md) | [40.9](/filings/0001558370-25-010299.md) | [40.9](/filings/0001104659-25-106299.md) | [41.0](/filings/0001104659-26-058670.md) | [40.9](/filings/0001104659-26-091151.md) | [41.0](/filings/0001104659-25-106299.md) | [43.4](/filings/0001104659-26-058670.md) | [43.4](/filings/0001104659-26-091151.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,820,734 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001104659-26-091151.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.